Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
European Journal of Immunology|October 15, 2014
Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 miceGera Goverse, Brenda J Olivier, Rosalie Molenaar, et al.
The Lancet. HIV|August 9, 2020
Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort studyMichael E Herce, Christopher J Hoffmann, Katherine Fielding, et al.
World Journal of Gastroenterology|July 29, 2006
Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shuntingSchalk W van der Merwe, Maria M Conradie, Robert Bond, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|October 17, 2024
Development of the "LAser Surgical skills Evaluation for Residents" (LASER) Scale Through a Modified Delphi MethodE Sédillot-Daniel, A Melkane, C Chiesa, et al.
Actas Urologicas Espanolas|January 26, 2026
Confirmatory MRI and re-Biopsy Findings during Active Surveillance in Patients with Grade Group 2 Prostate CancerF Sanguedolce, M Baboudjian, A Redondo Ríos, et al.
Molecular Cancer Therapeutics|November 28, 2013
MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitorsJonathan B Fitzgerald, Bryan W Johnson, Jason Baum, et al.
Frontiers in Global Women'S Health|July 4, 2025
Prevalence and factors associated with the use of modern contraceptive methods among female healthcare providers in health facilities in GuineaYamoussa Youla, Sidikiba Sidibé, Hounmenou Gc, et al.
Leukemia|April 9, 2016
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferationY Huang, J A I Thoms, M L Tursky, et al.
Nature Immunology|September 29, 2009
Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulationSerge A van de Pavert, Brenda J Olivier, Gera Goverse, et al.
Toxicology and Applied Pharmacology|June 9, 2012
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicityJoseph G Reynolds, Elena Geretti, Bart S Hendriks, et al.
Pageof 13